Remplir Used in 23 Surgeries in Ukrainian soldiers
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Orthocell Ltd has announced that its Remplir nerve repair device has been used in surgical procedures on injured soldiers in Ukraine. The device is designed to connect and protect severed nerves resulting from trauma and has received positive feedback from surgeons. Orthocell is evaluating further opportunities to engage with defense organizations globally based on this experience. The announcement highlights the device's portability and suitability for use in conflict settings.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Orthocell
- Orthocell Appoints UK Distributor for Remplir
- Appendix 4D & Half-Year Financial Report
- Orthocell Receives $3.0m R&D Tax Refund
- US Market and Operational Update
- Quarterly Activity Report & Appendix 4C
Later from Orthocell
- OCC Secures Access to 221 U.S. Military Medical Centres
- Orthocell Secures Approval to sell Remplir™ to the U.S. Department of Defence Hospital Network
- First Surgical Use of Remplir in US Department of Defense
- Q3 FY26 Investor Presentation
- Compelling 90% Success Rate for Remplir in Real World Study
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell